EUVIMEDEUVIMED entdecken
Crossref

Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment

Ashraf Albrakati

Indian Journal of Animal Research · 29.06.2026 · (Of)

DOI: 10.18805/ijar.bf-2135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Animal Research, online erschienen am 29.06.2026. Verfasst von Ashraf Albrakati.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases, including alzheimer’s disease (AD), parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), share interconnected pathogenic mechanisms-oxidative stress, mitochondrial dysfunction, neuroinflammation and progressive neuronal loss-for which available interventions remain largely symptomatic, sustaining interest in pleiotropic natural compounds. This critical narrative review evaluates prodigiosin-a bacterial tripyrrole pigment produced by serratia marcescens-as a candidate neuroprotective compound, situates its evidence against established natural antioxidants (Curcumin, quercetin and resveratrol) and identifies translational gaps through a structured gap analysis. A structured narrative search was conducted across PubMed, Scopus, Web of Science and Google Scholar (2010-2025), combining prodigiosin with neurodegeneration-related descriptors. Given the sparse and heterogeneous evidence base, a critical narrative rather than systematic review framework was applied. Prodigiosin may modulate multiple neuroprotective pathways: (1) Nrf2/HO-1 antioxidant activation (enhanced SOD, CAT, GPx; reduced MDA and nitric oxide); (2) NF-κB suppression (downregulated IL-1β, TNF-α, COX-2, iNOS); (3) apoptosis attenuation via Bcl-2/Bax modulation and caspase-3 reduction and (4) partial restoration of neurotransmitter and neurotrophic (BDNF) indices. However, the evidence derives predominantly from a single research cluster using aluminum chloride models and lacks pharmacokinetic characterization, blood-brain barrier penetration data, independent replication and transgenic model validation.

Zitieren

APA

Albrakati, A. (2026). Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment. Indian Journal of Animal Research. https://doi.org/10.18805/ijar.bf-2135

Vancouver

Albrakati A. Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment. Indian Journal of Animal Research. 2026. doi:10.18805/ijar.bf-2135

BibTeX
@article{Albrakati2026,
  author = {Albrakati, Ashraf},
  title = {Prodigiosin in Neurodegeneration: A Critical Review, Comparative Analysis and Translational Gap Assessment},
  journal = {Indian Journal of Animal Research},
  year = {2026},
  number = {Of},
  doi = {10.18805/ijar.bf-2135}
}
Kostenlos starten →